Aleitinib hydrochloride capsule is an antitumor drug used for the treatment of small cell lung cancer, which is a small molecule multi-targeted tyrosinase inhibitor, and it can also be simply considered as a targeted antitumor drug.
1. Aleitinib hydrochloride capsule is mainly used for the treatment of advanced metastatic non-small cell lung cancer with kinase-positive mesenchymal lymphoma, and it is used as the first-line treatment of this disease. Through the treatment of this drug, the survival period of many patients has been significantly improved. And this drug has now entered the medical insurance, after the negotiation of the National Health Insurance Bureau, the price is significantly lower than before.
2. But the medication must be taken at regular intervals according to the doctor’s requirements, in addition to pay attention to the drug may cause some adverse reactions, such as coughing, chest tightness, dyspnea, elevated liver enzymes, muscle pain, bradycardia and so on.
3. In addition to the childbearing age with the drug do not give birth to, lactating women in the period of use of the drug is recommended not to breastfeed.
This drug belongs to the prescription drugs, need to go to the hospital to find a specialist to develop a treatment plan.